Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Immunol. 2011 Aug 1;187(5):2569–2577. doi: 10.4049/jimmunol.1100374

Figure 2.

Figure 2

Peptide-stimulated CD8+ T cells primed in the absence of Tregs protect against Lm infection. Bacterial CFUs in the spleen (top) or liver (bottom) day 3 after infection with either Lm-OVA or Lm-10403s for the indicated mice stimulated with OVA257–264 peptide (and treated with DT one day prior and on the day of peptide inoculation) 30 days prior to infection. These data are representative of three experiments containing 8–12 mice per group.